BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 19531057)

  • 21. Inborn Errors of Metabolism with Hyperammonemia: Urea Cycle Defects and Related Disorders.
    Summar ML; Mew NA
    Pediatr Clin North Am; 2018 Apr; 65(2):231-246. PubMed ID: 29502911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonaemia due to ornithine transcarbamylase deficiency.
    Chen CY; Chen YC; Fang JT; Huang CC
    Ren Fail; 2000 Nov; 22(6):823-36. PubMed ID: 11104170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acrodermatitis enteropathica-like dermatosis associated with ornithine transcarbamylase deficiency.
    Pascual JC; Matarredona J; Mut J
    Pediatr Dermatol; 2007; 24(4):394-6. PubMed ID: 17845164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
    Mao X; Chen H; Lin AZ; Kim S; Burczynski ME; Na E; Halasz G; Sleeman MW; Murphy AJ; Okamoto H; Cheng X
    J Inherit Metab Dis; 2022 May; 45(3):470-480. PubMed ID: 34988999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges in diagnosing and managing adult patients with urea cycle disorders.
    Stepien KM; Geberhiwot T; Hendriksz CJ; Treacy EP
    J Inherit Metab Dis; 2019 Nov; 42(6):1136-1146. PubMed ID: 30932189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problems in the management of urea cycle disorders.
    Wilcken B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S86-91. PubMed ID: 15050980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency.
    Choi DE; Lee KW; Shin YT; Na KR
    J Korean Med Sci; 2012 May; 27(5):556-9. PubMed ID: 22563224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
    Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
    Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urea cycle disorders.
    Leonard JV; Morris AA
    Semin Neonatol; 2002 Feb; 7(1):27-35. PubMed ID: 12069536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperammonemia due to ornithine transcarbamylase deficiency--a cause of lethal metabolic crisis during the newborn period and infancy (author's transl)].
    Schuchmann L; Colombo JP; Fischer H
    Klin Padiatr; 1980 May; 192(3):281-5. PubMed ID: 7191930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
    Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
    Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urea cycle disorders in Thai infants: a report of 5 cases.
    Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
    Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
    Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Murayama K; Kubota M; Kurokawa K; Murakami T; Kanazawa M; Takatani T; Ogawa A; Ogawa E; Yamamoto S; Adachi M; Kobayashi K; Takayanagi M
    Eur J Pediatr; 2006 Sep; 165(9):618-24. PubMed ID: 16703326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.